GRI BIO INC (GRI) Stock Income Statement
USA - NASDAQ:GRI - US3622AW4030 - Common Stock
1.95 USD
+0.02 (+1.04%)
1.93 USD
-0.02 (-1.03%)
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 9.39M | 8.24M | 11.39M | 6.93M | 9.26M | |||
| Research and Development | 4.48M | N/A | 3.23M | 1.17M | 5.19M | |||
| Selling, General, and Administrative Expenses | 4.92M | 4.47M | 8.15M | 5.76M | 4.07M | |||
| Operating Income | -9.39M | -8.24M | -11.39M | -6.93M | -9.26M | |||
| Interest Income/Expense | 24.00K | N/A | -1.90M | 410.00K | -105.00K | |||
| Other Income/Expense | 0.00 | 0.00 | 250.00K | -506.00K | 61.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | N/A | N/A | |||
| Income Before Taxes | -9.37M | -8.21M | -13.04M | -7.02M | -9.30M | |||
| Net Income | -11.28M | -10.00M | -13.04M | -7.02M | -9.30M | |||
| EBITDA | N/A | -8.24M | -11.38M | -6.72M | -9.17M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -108.62 | -54.56 | -6.24K | -31.93K | -62.02K | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD